title: Ondansetron given intravenously attenuates arterial blood pressure drop due to spinal anesthesia: a double-blind, placebo-controlled study.
abstract: OBJECTIVE
  Side effects of spinal anesthesia include arterial hypotension and bradycardia. Both of them may be induced by sympathetic nerve blockade as well as by the Bezold-Jarisch reflex, which may be mediated by peripheral serotonin receptors (5-HT(3) type). The aim of this study was to verify the hypothesis that blockade of type 3 serotonin receptors by intravenous ondansetron administration might reduce hypotension and bradycardia induced by spinal anesthesia.
  
  
  METHODS
  Seventy-one patients participated in the study; 36 in the ondansetron group (receiving 8 mg intravenous ondansetron), and 35 in the placebo group (receiving isotonic NaCl solution). Measurements of heart rate and arterial blood pressure were taken every 5 minutes after spinal anesthesia was performed with 4 mL 0.5% hyperbaric bupivacaine solution.
  
  
  RESULTS
  Decreases in mean, systolic, and diastolic arterial pressure as well as in heart rate, compared with baseline values were observed in both groups. Minimal systolic and mean blood pressure values obtained over a 20-minute observation period were significantly higher in the ondansetron group. There were no significant differences in diastolic blood pressure and heart rate values between the groups.
  
  
  CONCLUSIONS
  Ondansetron given intravenously attenuates the fall of systolic and mean blood pressure, but does not have an influence on diastolic blood pressure or heart rate.
authors.affiliation: Department of Anaesthesiology and Intensive Therapy, Medical University of Gdansk, Gdansk, Poland. r.owczuk@amg.gda.pl <r.owczuk@amg.gda.pl>
authors.forename: Radoslaw
authors.initials: R
authors.lastname: Owczuk
authors.forename: Wojciech
authors.initials: W
authors.lastname: Wenski
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Polak-Krzeminska
authors.forename: Pawel
authors.initials: P
authors.lastname: Twardowski
authors.forename: Renata
authors.initials: R
authors.lastname: Arszułowicz
authors.forename: Anna
authors.initials: A
authors.lastname: Dylczyk-Sommer
authors.forename: Magdalena A
authors.initials: MA
authors.lastname: Wujtewicz
authors.forename: Wioletta
authors.initials: W
authors.lastname: Sawicka
authors.forename: Ewa
authors.initials: E
authors.lastname: Morzuch
authors.forename: Maciej
authors.initials: M
authors.lastname: Smietanski
authors.forename: Maria
authors.initials: M
authors.lastname: Wujtewicz
mesh_terms: D000328:Adult; D000368:Aged; D000775:Anesthesia, Spinal / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D017294:Ondansetron / Q000494:pharmacology*; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000494:pharmacology*
chemical_list: D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists; D017294:Ondansetron